| 000 | 01537 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515061121.0 | ||
| 264 | 0 | _c20070608 | |
| 008 | 200706s 0 0 eng d | ||
| 022 | _a1464-4096 | ||
| 024 | 7 |
_a10.1111/j.1464-410X.2007.06770.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShaw, Greg L | |
| 245 | 0 | 0 |
_aInternational study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate: a meta-analysis of 1446 patients. _h[electronic resource] |
| 260 |
_bBJU international _cMay 2007 |
||
| 300 |
_a1056-65 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Review | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAndrogen Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aAndrogens _xmetabolism |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aNeoplasm Recurrence, Local |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xmetabolism |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aWilson, Peter | |
| 700 | 1 | _aCuzick, Jack | |
| 700 | 1 | _aProwse, David M | |
| 700 | 1 | _aGoldenberg, S Larry | |
| 700 | 1 | _aSpry, Nigel A | |
| 700 | 1 | _aOliver, Tim | |
| 773 | 0 |
_tBJU international _gvol. 99 _gno. 5 _gp. 1056-65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1464-410X.2007.06770.x _zAvailable from publisher's website |
| 999 |
_c16902735 _d16902735 |
||